Polymers containing biological materials

Polymers containing biological materials are frequently named starting with the biological, using the singular polymer with when the first term is singular and the polymers with if the first terms are plural. For example, [r]osin, polymer with formaldehyde, methanol and phenol CAS Number... 

The application of polymer monoliths in 2D separations, however, is very attractive in that polymer-based packing materials can provide a high performance, chemically stable stationary phase, and better recovery of biological molecules, namely proteins and peptides, even in comparison with C18 phases on silica particles with wide mesopores (Tanaka et al., 1990). Microchip fabrication for 2D HPLC has been disclosed in a recent patent, based on polymer monoliths (Corso et al., 2003). This separation system consists of stacked separation blocks, namely, the first block for ion exchange (strong cation exchange) and the second block for reversed-phase separation. This layered separation chip device also contains an electrospray interface microfabricated on chip (a polymer monolith/... 

The TSCA Inventory provides an overall picmre of the organic, inorganic, polymers, and UVCB (chemical substances of Unknown, or Variable Composition, Complex Reaction Products, and Biological Materials) chemicals produced, processed, or imported for commercial purposes in the United States. The Inventory is not a list of chemicals based on toxic or hazardous characteristics, since toxicity/hazard is not a criterion for inclusion in the list. The Inventory includes chemical substances of any commercial use in the United States since 1979 under the Environmental Protection Act, and is prepared by the US-EPA. The current TSCA Inventory contains approximately 81,600 chemicals. Currently, OPPT is focusing on a subset of approximately 3,000 HPV... 

Methods for preparing heparin-containing polymeric materials by means of ionic and covalent immobilization of heparin on various polymers are surveyed. The data on the biological activity of heparin are discussed as well as the probable mechanisms of thromboresistance enhancement endowed to polymeric materials by this anticoagulant. Some approaches toward an increased efficiency of anticoagulant properties of immobilized heparin are analyzed, and the position of heparin-containing polymers among other biomedical polymers is discussed. 

Biological responses are typically dependent on a number of test parameters Including state of the tested material (solid or In solution), solvent, organism and test procedure. Since test results are dependent on these variables. It Is advantageous to associate testing conditions with an Intended application. Much of our research with polymers containing tin, antimony and arsenic Is associated with control of mildew and rot for eventual application In topical medications, as thermal Insulation and as additives In paints, textiles and paper products. 

---